Research ArticleAccepted Article
Mixed airway and pulmonary parenchymal disease in patients with primary Sjögren’s Syndrome - a six-year follow-up
Anna Matilda Nilsson, H. Laura Aaltonen, Peter Olsson, Hans Lennart Persson, Roger Hesselstrand, Elke Theander, Per Wollmer and Thomas Mandl
The Journal of Rheumatology June 2020, jrheum.200247; DOI: https://doi.org/10.3899/jrheum.200247
Anna Matilda Nilsson
Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Department of Rheumatology, Linköping University Hospital, Linköping, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Respiratory Medicine in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Jansen Cilag, Solna, Sweden; Novartis, Kista, Sweden. The study was supported by grants from ALF-Skåne, the Internal Research Funds of Skåne University Hospital, the Swedish Rheumatism Association and the Swedish Heart and Lung Foundation. Address correspondence to Anna Matilda Nilsson, E-mail: anna1.nilsson@med.lu.se
H. Laura Aaltonen
Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Department of Rheumatology, Linköping University Hospital, Linköping, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Respiratory Medicine in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Jansen Cilag, Solna, Sweden; Novartis, Kista, Sweden. The study was supported by grants from ALF-Skåne, the Internal Research Funds of Skåne University Hospital, the Swedish Rheumatism Association and the Swedish Heart and Lung Foundation. Address correspondence to Anna Matilda Nilsson, E-mail: anna1.nilsson@med.lu.se
Peter Olsson
Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Department of Rheumatology, Linköping University Hospital, Linköping, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Respiratory Medicine in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Jansen Cilag, Solna, Sweden; Novartis, Kista, Sweden. The study was supported by grants from ALF-Skåne, the Internal Research Funds of Skåne University Hospital, the Swedish Rheumatism Association and the Swedish Heart and Lung Foundation. Address correspondence to Anna Matilda Nilsson, E-mail: anna1.nilsson@med.lu.se
Hans Lennart Persson
Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Department of Rheumatology, Linköping University Hospital, Linköping, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Respiratory Medicine in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Jansen Cilag, Solna, Sweden; Novartis, Kista, Sweden. The study was supported by grants from ALF-Skåne, the Internal Research Funds of Skåne University Hospital, the Swedish Rheumatism Association and the Swedish Heart and Lung Foundation. Address correspondence to Anna Matilda Nilsson, E-mail: anna1.nilsson@med.lu.se
Roger Hesselstrand
Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Department of Rheumatology, Linköping University Hospital, Linköping, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Respiratory Medicine in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Jansen Cilag, Solna, Sweden; Novartis, Kista, Sweden. The study was supported by grants from ALF-Skåne, the Internal Research Funds of Skåne University Hospital, the Swedish Rheumatism Association and the Swedish Heart and Lung Foundation. Address correspondence to Anna Matilda Nilsson, E-mail: anna1.nilsson@med.lu.se
Elke Theander
Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Department of Rheumatology, Linköping University Hospital, Linköping, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Respiratory Medicine in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Jansen Cilag, Solna, Sweden; Novartis, Kista, Sweden. The study was supported by grants from ALF-Skåne, the Internal Research Funds of Skåne University Hospital, the Swedish Rheumatism Association and the Swedish Heart and Lung Foundation. Address correspondence to Anna Matilda Nilsson, E-mail: anna1.nilsson@med.lu.se
Per Wollmer
Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Department of Rheumatology, Linköping University Hospital, Linköping, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Respiratory Medicine in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Jansen Cilag, Solna, Sweden; Novartis, Kista, Sweden. The study was supported by grants from ALF-Skåne, the Internal Research Funds of Skåne University Hospital, the Swedish Rheumatism Association and the Swedish Heart and Lung Foundation. Address correspondence to Anna Matilda Nilsson, E-mail: anna1.nilsson@med.lu.se
Thomas Mandl
Department of Clinical Sciences Malmö, Lund University, Malmö, Sweden; Department of Rheumatology, Linköping University Hospital, Linköping, Sweden; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Respiratory Medicine in Linköping and Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Clinical Sciences Lund, Lund University, Lund, Sweden; Jansen Cilag, Solna, Sweden; Novartis, Kista, Sweden. The study was supported by grants from ALF-Skåne, the Internal Research Funds of Skåne University Hospital, the Swedish Rheumatism Association and the Swedish Heart and Lung Foundation. Address correspondence to Anna Matilda Nilsson, E-mail: anna1.nilsson@med.lu.se
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Accepted manuscript
Mixed airway and pulmonary parenchymal disease in patients with primary Sjögren’s Syndrome - a six-year follow-up
Anna Matilda Nilsson, H. Laura Aaltonen, Peter Olsson, Hans Lennart Persson, Roger Hesselstrand, Elke Theander, Per Wollmer, Thomas Mandl
The Journal of Rheumatology Jun 2020, jrheum.200247; DOI: 10.3899/jrheum.200247
Accepted manuscript
Mixed airway and pulmonary parenchymal disease in patients with primary Sjögren’s Syndrome - a six-year follow-up
Anna Matilda Nilsson, H. Laura Aaltonen, Peter Olsson, Hans Lennart Persson, Roger Hesselstrand, Elke Theander, Per Wollmer, Thomas Mandl
The Journal of Rheumatology Jun 2020, jrheum.200247; DOI: 10.3899/jrheum.200247